Mesotherapy should not replace the surgical approach in the treatment of benign symmetric lipomatosis.

摘要

We comment on the article by Hasegawa et al. [1] entitled Mesotherapy for Benign Symmetric Lipomatosis. Benign symmetric lipomatosis is a rare disorder characterized by multiple, symmetric, nonencapsulated fat masses in different body areas creating significant cosmetic deformity. Brodie [2] first described benign symmetric lipomatosis (BSL) in 1946, and Madelung [3], who named the syndrome, further characterized it, reporting 33 cases in 1888.